CareDx (CDNA) Stock Forecast, Price & News

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CareDx in the last twelve months. There are currently 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CDNA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CDNA, but not buy additional shares or sell existing shares.
View CDNA analyst ratings or view top-rated stocks.

5 brokerages have issued 12 month target prices for CareDx's shares. Their CDNA share price forecasts range from $9.00 to $25.00. On average, they predict the company's stock price to reach $16.00 in the next year. This suggests a possible upside of 96.8% from the stock's current price.
View analysts price targets for CDNA or view top-rated stocks among Wall Street analysts.

CareDx's stock was trading at $11.41 at the beginning of 2023. Since then, CDNA stock has decreased by 28.7% and is now trading at $8.13.
View the best growth stocks for 2023 here.

CareDx saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 6,200,000 shares, an increase of 19.2% from the April 30th total of 5,200,000 shares. Based on an average trading volume of 1,380,000 shares, the short-interest ratio is presently 4.5 days. Approximately 12.0% of the shares of the stock are short sold.
View CareDx's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our CDNA earnings forecast.

CareDx, Inc (NASDAQ:CDNA) announced its earnings results on Thursday, October, 28th. The company reported $0.07 earnings per share for the quarter, topping the consensus estimate of ($0.14) by $0.21. The business earned $75.60 million during the quarter, compared to the consensus estimate of $74.11 million. CareDx had a negative trailing twelve-month return on equity of 18.65% and a negative net margin of 25.25%. The business's revenue for the quarter was up 41.6% compared to the same quarter last year. During the same period last year, the business posted ($0.06) earnings per share.

ETFs with the largest weight of CareDx (NASDAQ:CDNA) stock in their portfolio include ARK Genomic Revolution ETF (ARKG), Jacob Forward ETF (JFWD), ROBO Global Healthcare Technology and Innovation ETF (HTEC), Global X Genomics & Biotechnology ETF (GNOM), SPDR S&P Biotech ETF (XBI), Direxion Daily S&P Biotech Bull 3x Shares (LABU), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) and Principal Healthcare Innovators ETF (BTEC).

Based on aggregate information from My MarketBeat watchlists, some companies that other CareDx investors own include Block (SQ), Roku (ROKU), Exact Sciences (EXAS), NVIDIA (NVDA), Advanced Micro Devices (AMD), Tesla (TSLA), Enphase Energy (ENPH), Johnson & Johnson (JNJ), Activision Blizzard (ATVI) and Alibaba Group (BABA).

CareDx trades on the NASDAQ under the ticker symbol "CDNA."

CareDx's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include ARK Investment Management LLC (12.67%), State Street Corp (9.07%), BlackRock Inc. (8.13%), Armistice Capital LLC (5.83%), Sumitomo Mitsui Trust Holdings Inc. (5.12%) and Nikko Asset Management Americas Inc. (5.12%). Insiders that own company stock include Ankur Dhingra, George Bickerstaff, Grace Colon, Michael Brian Bell, Michael Goldberg, Paul Adler, Peter Maag, Ralph Snyderman, Reginald Seeto, Sasha King, Thomas A Thomas and William A Hagstrom.
View institutional ownership trends.

Shares of CDNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CDNA stock can currently be purchased for approximately $8.13.

CareDx (NASDAQ:CDNA) has a market capitalization of $437.34 million and generates $319.64 million in revenue each year. The company earns $-76,610,000.00 in net income (profit) each year or ($1.51) on an earnings per share basis.

The company employs 633 workers across the globe.

CareDx's mailing address is 1 TOWER PLACE 9TH FLOOR, SOUTH SAN FRANCISCO CA, 94080. The official website for the company is www.caredxinc.com. The company can be reached via phone at (415) 287-2300, via email at caroline.corner@westwicke.com, or via fax at 415-287-2450.